34 related articles for article (PubMed ID: 30737029)
1. Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.
Palmini G; Romagnoli C; Donati S; Zonefrati R; Galli G; Marini F; Iantomasi T; Aldinucci A; Leoncini G; Franchi A; Beltrami G; Campanacci DA; Capanna R; Brandi ML
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503899
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
Zhou Y; Ray PS; Zhu J; Stein F; Rettel M; Sekaran T; Sahadevan S; Perez-Perri JI; Roth EK; Myklebost O; Meza-Zepeda LA; von Deimling A; Fu C; Brosig AN; Boye K; Nathrath M; Blattmann C; Lehner B; Hentze MW; Kulozik AE
Nat Commun; 2024 Apr; 15(1):2810. PubMed ID: 38561347
[TBL] [Abstract][Full Text] [Related]
3. Exosomes in osteosarcoma research and preclinical practice.
Zhang XB; Zhang RH; Su X; Qi J; Hu YC; Shi JT; Zhang K; Wang KP; Zhou HY
Am J Transl Res; 2021; 13(3):882-897. PubMed ID: 33841628
[TBL] [Abstract][Full Text] [Related]
4. miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling.
Wang Q; Liu MJ; Bu J; Deng JL; Jiang BY; Jiang LD; He XJ
Life Sci; 2021 Mar; 268():118925. PubMed ID: 33358903
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
6. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
7. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
8. MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt.
Ru N; Zhang F; Liang J; Du Y; Wu W; Wang F; Liu X
Gene; 2018 Mar; 645():163-169. PubMed ID: 29248580
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma.
Liu W; Zhou Z; Zhang Q; Rong Y; Li L; Luo Y; Wang J; Yin G; Lv C; Cai W
Biochem Biophys Res Commun; 2019 Mar; 510(3):479-486. PubMed ID: 30737029
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach.
Shabani P; Izadpanah S; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):4783-4793. PubMed ID: 30450580
[TBL] [Abstract][Full Text] [Related]
11. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
Yang Z; Liu T; Ren X; Yang M; Tu C; Li Z
Cell Cycle; 2022 Oct; 21(20):2121-2131. PubMed ID: 35699451
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the functional role of microRNA 21 in osteosarcoma.
Sekar D; Mani P; Biruntha M; Sivagurunathan P; Karthigeyan M
Cancer Gene Ther; 2019 Jul; 26(7-8):179-182. PubMed ID: 30905966
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]